24 April 2015, 5:00 pm
The BioSure HIV Self Test, designed to be used by untrained users at home was granted a CE mark yesterday, making it the first HIV home test which can be legally sold in the United Kingdom. The test is simple to perform and tests for the presence of HIV antibodies in a

24 April 2015, 2:50 pm
There is a strong interest among people living with HIV in studies towards an HIV cure, with many potential participants willing to consider antiretroviral treatment interruption. Respondents to a survey presented at the British HIV Association conference in Brighton this week generally understood that they would be unlikely to benefit personally from cure research. Priorities

24 April 2015, 12:40 pm
A 12-week course of the combination of grazoprevir and elbasvir cured 95% of previously untreated people with genotypes 1, 4 or 6 hepatitis C virus (HCV), according to results of the C-EDGE trial, presented on Friday at the International Liver Congress in Vienna, Austria. However, the study also showed that people with higher baseline HCV

24 April 2015, 7:30 am
A small study assessing the infectiousness of HIV-positive gay men taking antiretroviral therapy has found that all study participants had an undetectable viral load in the rectum. Men who had rectal gonhorroea or chlamydia didn’t have detectable virus either, suggesting that concerns about sexually transmitted infections raising the risk of HIV transmission may be unfounded

24 April 2015, 7:10 am
An oral regimen of sofosbuvir/ledipasvir (Harvoni) and ribavirin taken for 12 or 24 weeks produced sustained virological response (SVR) rates of 85-88% for people with genotype 1 or 4 hepatitis C virus (HCV) who had decompensated cirrhosis and 95-98% for liver transplant recipients with less advanced liver damage, according to results from

1 2

    • No upcoming events
  • View All Add your news